Dicot Pharma receives FDA clearance to start Phase 2b study of LIB-01 in US
CeleCor Therapeutics submits final section of zalunfiban (Disaggpro) New Drug Application to US FDA
Thalia Therapeutics acquires Sanmirna and raises GBP2.75m to advance AML RNA therapy
ZETA SURGICAL reports first patient treated with Zeta TMS Navigation System at HOPE Therapeutics
EU approves Cenrifki for secondary progressive multiple sclerosis without relapses
Genprex receives Canadian Patent Allowance for Reqorsa gene therapy combination in lung cancer
Solvonis reports positive bridging data for SVN-002 ahead of planned US Phase 2b
FDA accepts Genentech application for Lunsumio and Polivy combination in large B-cell lymphoma